Benzinga | Feb 23, 2021 04:15PM EST

Corcept Therapeutics Q4 EPS $0.27 Beats $0.19 Estimate, Sales $85.70M Miss $87.77M Estimate

Corcept Therapeutics (NASDAQ:CORT) reported quarterly earnings of $0.27 per share which beat the analyst consensus estimate of $0.19 by 42.11 percent. This is a 18.18 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $85.70 million which missed the analyst consensus estimate of $87.77 million by 2.36 percent. This is a 2.50 percent decrease over sales of $87.89 million the same period last year.